Phreesia Price to Sales Ratio 2019-2024 | PHR
Historical PS ratio values for Phreesia (PHR) over the last 10 years. The current P/S ratio for Phreesia as of November 12, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Phreesia P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-11-12 | 21.37 | 3.07 | |
| 2024-07-31 | 24.95 | $6.96 | 3.58 |
| 2024-04-30 | 20.74 | $6.78 | 3.06 |
| 2024-01-31 | 25.48 | $6.57 | 3.88 |
| 2023-10-31 | 13.66 | $6.29 | 2.17 |
| 2023-07-31 | 31.72 | $6.02 | 5.27 |
| 2023-04-30 | 31.64 | $5.72 | 5.53 |
| 2023-01-31 | 37.49 | $5.37 | 6.99 |
| 2022-10-31 | 27.32 | $5.07 | 5.39 |
| 2022-07-31 | 23.49 | $4.78 | 4.92 |
| 2022-04-30 | 22.88 | $4.49 | 5.10 |
| 2022-01-31 | 31.19 | $4.33 | 7.20 |
| 2021-10-31 | 70.54 | $4.23 | 16.69 |
| 2021-07-31 | 68.35 | $4.13 | 16.56 |
| 2021-04-30 | 51.75 | $4.05 | 12.78 |
| 2021-01-31 | 65.29 | $3.88 | 16.83 |
| 2020-10-31 | 36.97 | $4.44 | 8.33 |
| 2020-07-31 | 30.06 | $4.36 | 6.90 |
| 2020-04-30 | 25.39 | $7.97 | 3.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.235B | $0.356B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.733B | 148.28 |
| Inspire Medical Systems (INSP) | United States | $5.716B | 178.27 |
| Axonics (AXNX) | United States | $3.603B | 1762.25 |
| IRhythm Technologies (IRTC) | United States | $2.729B | 0.00 |
| Privia Health (PRVA) | United States | $2.710B | 225.80 |
| Enovis (ENOV) | United States | $2.621B | 17.77 |
| Omnicell (OMCL) | United States | $2.264B | 74.08 |
| Azenta (AZTA) | United States | $2.250B | 112.17 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Schrodinger (SDGR) | United States | $1.620B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.617B | 0.00 |
| Standard BioTools (LAB) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.569B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.528B | 91.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.278B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.261B | 0.00 |
| TruBridge (TBRG) | United States | $0.234B | 67.96 |
| P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.098B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.017B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |